Synthesis of new ethyl 4-[3-(Dimethylamino)-propylmethylamino]pyrrolo[1,2-α]quinoxaline-2-carboxylate derivatives and preliminary CNS pharmacological evaluation in mice

Pharmacy and Pharmacology Communications

Volumn 4, Issue 7, 1998, Pages 319-324

  Guillon, J ^b   Louchahi Raoul, J ^b   Boulouard, M ^b   Dallemagne, P ^b   Daoust, M ^a   Rault, S ^b  

^a UNIVERSITÉ DE CAEN   (France)

^b CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CONVULSANT AGENT; ETHYL 4 (3 (DIMETHYLAMINO)PROPYLMETHYLAMINO)PYRROLO(1,2)QUINOXALINE 2 CARBOXYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0031846131     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Acheson, R. M. (1956) Several quinoxalines of biological interest. J. Chem. Soc. 4731-4735
2. Alazard, J. P., Boyé, O., Gillet, B., Guénard, D., Beloeil, J. C., Thai, C. (1993) Composés interagissant avec la tubuline. Partie I: synthèse de phénylpyrroles ortho-ortho' substitués en rotation libre ou empêchée. Bull. Soc. Chim. Fr. 130: 779-787
3. Berlin, A., Martina, S., Pagani, G., Schiavon, G., Zotti, G. (1991) Synthesis of the parent systems of dipyrrolo[1,2-a:2′,1′-c]pyrazine and of dipyrrolo[1,2-a:2′,1′-c]quinoxaline. Heterocycles 32: 85-92
4. Bertelli, L., Biagi, G., Giorgi, I., Manera, C., Livi, O., Scartoni, V., Betti, L., Giannaccini, G., Trincavelli, L., Barili, P. L. (1998) 1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. Eur. J. Med. Chem. 33: 113-122
5. Blache, Y., Gueiffier, A., Chavignon, O., Teulade, J. C., Molhavet, J. C., Viols, H., Chapat, J. P., Dauphin, G. (1994) Heterocyclization in the pyrido[2,3-b]pyrazine series. J. Heterocyclic Chem. 31: 161-166
6. Blache, Y., Gueiffier, A., Elhakmaoui, A., Viols, H., Chapat, J. P., Chavignon, O., Teulade, J. C., Grassy, G., Dauphin, G., Carpy, A. (1995) Synthesis and reactivity of pyrrolo[1,2-a]quinoxalines. Crystal structure and AM1 calculation. J. Heterocyclic Chem. 32: 1317-1324
7. Catarzi, D., Cecchi, L., Colotta, V., Melani, F., Filacchioni, G., Martini, C., Giusti, L., Luccachini, A. (1994) Structure-activity relationships of 1,2,4-triazolo[1,5-a]quinoxalines and their 1-deaza analogues imidazo[1,2-a] quinoxalines at the benzodiazepine receptor. J. Med. Chem. 37: 2846-2850
8. Cheeseman, G. W. H. (1957) Quinoxalines and related compounds. Part III. Some 2-substituted quinoxalines. J. Chem. Soc. 3236-3239
9. Cheeseman, G. W. H., Tuck, B. (1965) A new synthesis of pyrrolo[1,2-a]quinoxalines. Chem. Ind. 31: 1382
10. Cheeseman, G. W. H., Tuck, B. (1966) The synthesis of pyrrolo[1,2-a]quinoxalines from N-(2-acetylaminophenyl)-pyrroles. J. Chem. Soc. 852-855
11. Collins, J. L., Dambek, P. J., Goldstein, S. W., Faraci, W. S. (1992) CP-99,711: a non-peptide glucagon receptor antagonist. Bioorg. Med. Chem. Lett. 2: 915-918
12. Dawson, W., Newbold, G. T., Spring, F. S. (1949) Quinoxaline oxides. Part II. The action of hydrochloric acid on 3-ethoxy-2-methylquinoxaline 1-oxide. J. Chem. Soc. 2579-2582
13. Evoniuk, G., Skolnick, P. (1988) Anion regulation of agonist and inverse agonist binding to benzodiazepine receptors. J. Neurochem. 51: 1169-1175
14. Finney, D. J. (1971) The Spearman-Kärber method. In: Statistical Method in Biological Assay. C. Griffin & Co, London, pp 524-530
15. Gowenlock, A. H., Newbold, G. T., Spring, F. S. (1945) Syntheses of 2-monosubstituted and 2:3-disubstituted quinoxalines. J. Chem. Soc. 622-625
16. Guillon, J, Dallemagne, P., Pfeiffer, B., Renard, P., Manechez, D., Kervran, A., Rault, S. (1998) Synthesis of new pyrrolo[1,2-a]quinoxalines: potential non-peptide glucagon receptor antagonists. Eur. J. Med. Chem. 33: 293-308
17. Haefely, W., Kyburz, E., Gerecke, M., Möhler, H., (1985) Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists. Adv. Drug Res. 14: 166-299
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
19. Morpugo, C. (1971) A new design for the screening of CNS-active drugs in mice. Arzneim. Forsch. Drug Res. 21: 1727-1734
20. Pailer, M., Pruckmayr, G., Zellner, H., Zellner, G. (1962) Synthesen von chinoxalonderivaten. Monatsh. Chem. 93: 1005-1018
21. 1-Sulphanilamides derived from aminoquinoxalines and aminomethylquinoxalines. J. Chem. Soc. 2129-2134
22. Takada, S., Shindo, H., Sasatani, T., Chomei, N., Matsushita, A., Eigyo, M., Kawasaki, K., Murata, S., Takahara, Y., Shintaku, H. (1988) Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors. J. Med. Chem. 31: 1738-1745
23. Tang, A. H., Franklin, S. R., Himes, C. S., Ho, P. M. (1991) Behavioral effects of U-78875, a quinoxaline anxiolytic with potent benzodiazepine antagonist activity. J. Pharmacol. Exp. Ther. 259: 248-254